{
    "clinical_study": {
        "@rank": "6545", 
        "arm_group": [
            {
                "arm_group_label": "AL-60371/AL-817", 
                "arm_group_type": "Experimental", 
                "description": "AL-60371/AL-817 otic suspension, 1 drop in study ear through tympanostomy tube on Day 1 (Visit 1)"
            }, 
            {
                "arm_group_label": "CIPRODEX", 
                "arm_group_type": "Active Comparator", 
                "description": "Ciprofloxacin 0.3%/dexamethasone 0.1% otic suspension, 4 drops in study ear twice daily through tympanostomy tube for 7 days"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate a single application of AL-60371/AL-817 Otic\n      Suspension relative to ototopical CIPRODEX for microbiological success at Day 8 and time to\n      cessation of otorrhea."
        }, 
        "brief_title": "Proof-of-Concept Study of a Single Application of an Investigational Otic Suspension in Treatment of Acute Otitis Media With Tympanostomy Tubes", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Otitis Media", 
        "condition_browse": {
            "mesh_term": [
                "Otitis", 
                "Otitis Media"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Parent or guardian: Read and sign the informed consent. When required by the\n             Institutional Review Board, child must agree to sign an approved assent form;\n\n          -  Presence of otorrhea (visible by parent or guardian) of 21 days or less in duration;\n\n          -  Presence of patent tympanostomy tubes;\n\n          -  Refrain from water immersion of the ears following surgery without the use of\n             adequate ear protection during swimming, bathing, showering and other water-related\n             activities;\n\n          -  Parent or guardian: Agree to comply with the requirements of the study, administer\n             the study medication as directed, complete required study visits, and comply with the\n             protocol;\n\n          -  Other protocol-defined inclusion criteria may apply.\n\n        Exclusion Criteria:\n\n          -  NOT otorrhea-free for at least seven days following tympanostomy tube surgery;\n\n          -  Menarcheal females;\n\n          -  Previous otologic surgery, except tympanic membrane, within one year of study entry;\n\n          -  History of/or current acute or chronic non-tube otorrhea (through existing\n             perforation of the eardrum);\n\n          -  Current acute otitis externa, malignant otitis externa, or other conditions which\n             could interfere with evaluation of the study drug;\n\n          -  Diabetic (controlled or uncontrolled);\n\n          -  Use of prohibited medications;\n\n          -  Other protocol-defined exclusion criteria may apply."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "12 Years", 
            "minimum_age": "6 Months"
        }, 
        "enrollment": {
            "#text": "140", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01908803", 
            "org_study_id": "C-13-026"
        }, 
        "intervention": [
            {
                "arm_group_label": "AL-60371/AL-817", 
                "intervention_name": "AL-60371/AL-817 otic suspension", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "CIPRODEX", 
                "description": "CIPRODEX\u00ae", 
                "intervention_name": "Ciprofloxacin 0.3%/dexamethasone 0.1% otic suspension", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ciprofloxacin", 
                "BB 1101", 
                "Dexamethasone acetate", 
                "Dexamethasone", 
                "Dexamethasone 21-phosphate"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "AOMT", 
            "tympanostomy tubes", 
            "Otorrhea", 
            "anti-infective"
        ], 
        "lastchanged_date": "April 28, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Fort Worth", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "76134"
                }, 
                "name": "Contact Alcon Call Center for Trial Locations"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "alcon.medinfo@alcon.com", 
            "last_name": "Alcon Call Center", 
            "phone": "1-888-451-3937"
        }, 
        "overall_official": {
            "affiliation": "Alcon Research", 
            "last_name": "Celeste McLean, BS, MT (ASCP)", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "A sustained clinical cure at Day 3 will be attained if otorrhea is absent at the Day 3 visit and continues to be absent through the last study visit (Day 8 or Early Exit).", 
            "measure": "Proportion of subjects with sustained clinical cure at Day 3 visit", 
            "safety_issue": "No", 
            "time_frame": "Day 3"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01908803"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Microbiological success will be attained if all pre-therapy bacteria are absent in the Day 8 specimen. If no otorrhea at Day 8, eradication of pre-therapy bacteria will be presumed and the subject will be considered a microbiological success.", 
                "measure": "Proportion of subjects with microbiological success at the Day 8 visit", 
                "safety_issue": "No", 
                "time_frame": "Day 8"
            }, 
            {
                "description": "The time (in days) to the cessation of otorrhea (ie, otorrhea is absent) will be calculated as the number of days from the Day 1 (Visit 1) to the absence of otorrhea in the study ear as recorded by the parent/guardian via the twice-daily diary. Cessation of otorrhea will be defined as ending on the first day that otorrhea is absent from the study ear and remains absent for any/all subsequent diary entries.", 
                "measure": "Time (in days) to cessation of otorrhea", 
                "safety_issue": "No", 
                "time_frame": "Time to event, up to Day 8"
            }
        ], 
        "source": "Alcon Research", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Alcon Research", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}